Bone marrow-derived mesenchymal stem cells become antiangiogenic when chondrogenically or osteogenically differentiated: Implications for bone and cartilage tissue engineering

Tissue Engineering - Part A

Volumn 20, Issue 1-2, 2014, Pages 147-159

  Bara, Jennifer J ^a   McCarthy, Helen E ^b   Humphrey, Emma ^c   Johnson, William E B ^d   Roberts, Sally ^c  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CARTILAGE; CELL CULTURE; MASS SPECTROMETRY; PELLETIZING; PROTEINS; STEM CELLS; TISSUE; TISSUE ENGINEERING; TUBES (COMPONENTS);

ARTICULAR CARTILAGES; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; OSTEOCHONDRAL TISSUE ENGINEERING; OSTEOCHONDRAL TISSUES; OSTEOGENIC DIFFERENTIATION; UNDIFFERENTIATED CELLS; VASCULARIZED TISSUES;

ENDOTHELIAL CELLS;

MATRIGEL; NEUROTROPHIC FACTOR; OSTEOGENIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE MARROW; BONE TISSUE; CARTILAGE; CELL DIFFERENTIATION; CHONDROGENESIS; CULTURE MEDIUM; EQUIDAE; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MESENCHYMAL STEM CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN MICROARRAY; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; BONE AND BONES; BONE MARROW CELLS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CHROMATOGRAPHY, LIQUID; COLLAGEN; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; ENDOTHELIUM; HORSES; HUMANS; KINETICS; LAMININ; MASS SPECTROMETRY; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; PHENOTYPE; PROTEOGLYCANS; PROTEOMICS; TISSUE ENGINEERING;

EID: 84891501943     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0196     Document Type: Article

References (54)

1. Reed, A.A., Joyner, C.J., Isefuku, S., Brownlow, H.C., and Simpson, A.H. Vascularity in a new model of atrophic nonunion. J Bone Joint Surg Br 85-B, 604, 2003.
2. Brown, R.A., and Weiss, J.B. Neovascularisation and its role in the osteoarthritic process. Ann Rheum Dis 47, 881, 1988.
3. Walsh, D.A. Angiogenesis in osteoarthritis and spondylosis: successful repair with undesirable outcomes. Curr Opin Rheumatol 16, 609, 2004.
4. Bonnet, C.S., and Walsh, D.A. Osteoarthritis, angiogenesis and inflammation. Rheumatology 44, 7, 2005.
5. Roberts, S., McCall, I.W., Darby, A.J., Menage, J., Evans, H., Harrision, P.E., and Richardson, J.B. Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res and Ther 5, R60, 2003.
6. O'Shea, T.M., and Miao, X. Bilayered scaffolds for osteochondral tissue engineering. Tissue Eng Part B 14, 4, 2008.
7. Ishaug-Riley, S.L., Crane-Kruger, G.M., Yaszemski, M.J., and Mikos, A.G. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials 19, 15, 1998.
8. Altmann, B., Steinberg, T., Giselbrecht, S., Gottwald, E., Tomakidi, P., Bächle-Haas, M., and Kohal, R.J. Promotion of osteoblast differentiation in 3D biomaterial micro-chip arrays comprising fibronectin-coated poly(methyl methacrylate) polycarbonate. Biomaterials 32, 34, 2011.
9. Zhao, J., Han, W., Chen, H., Tu, M., Huan, S., Miao, G., Zeng, R., Wu, H., Cha, Z., and Zhou, C. Fabrication and in vivo osteogenesis of biomimetic poly(propylene carbonate) scaffold with nanofibrous chitosan network in macropores for bone tissue engineering. J Mater Sci Mater Med 23, 2, 2012.
10. Yu, H., VandeVord, P.J., Gong, W., Wu, B., Song, Z., Matthew, H.W., Wooley, P.H., and Yang, S.Y. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J Orthop Res 26, 8, 2008.
11. Koob, S., Torio-Padron, N., Stark, B.G., Hannig, C., Stankovic, Z., and Finkenzeller, G. Bone formation and neovascularisation mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng Part A 17, 3, 2011.
12. Murphy, W.L., Simmons, C.A., Kaigler, D., and Mooney, D.J. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 83, 3, 2004.
13. Kaigler, D., Wang, Z., Horger, K., Mooney, D., and Krebsbach, P.H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21, 5, 2006.
14. Warnke, P.H., Springer, I.N., Wiltfang, J., Acil, Y., and Eufinger, H. Growth and transplantation of a custom vascularised bone graft in man. Lancet 364, 9436, 2004.
15. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., Kon, E., and Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med. 344, 5, 2001.
16. Marcacci, M., Kon, E., Moukhachev, V., Lavroukov, A., Kutepov, S., Quarto, R., Mastrogiacomo, M., and Cancedda, R. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13, 5, 2007.
17. Kuroda, R., Ishida, K., Matsumoto, T., Akisue, T., Fujioka, H., Mizuno, K., Ohgushi, H., Wakitani, S., and Kurosaka, M. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 15, 2, 2007.
18. Nejadnik, H., Hui, J.H., Feng Choong, E.P., Tai, B.C., and Lee, E.H. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 38, 6, 2010.
19. Wakitani, S., Okabe, T., Horibe, S., Mitsuoka, T., Saito, M., Koyama, T., Nawata, M., Tensho, K., Kato, H., Uematsu, K., Kuroda, R., Kurosaka, M., Yoshiya, S., Hattori, K., and Ohgushi, H. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartialge repair in 41 patients with 45 joints followed up to 11 years and 5 months. J Tissue Eng Regen Med 5, 2, 2011.
20. Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., and Epstein, S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678, 2004.
21. Hung, S.C., Pochampally, R.R., Chen, S.C., Hsu, S.C., and Prockop, D.J. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25, 2363, 2007.
22. Wang, C.Y., Yang, H.B., Hsu, H.S., Chen, L.L., Tsai, C.C., Tsai, K.S., Yew, T.L., Kao, Y.H., and Hung, S.C. Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats. J Tissue Eng Regen Med 6, 7, 2012.
23. Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M., Yamagishi, M., Mori, H., Kangawa, K., and Kitamura, S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287, H2670, 2004.
24. Huang, N.F., Lam, A., Fang, Q., Sievers, R.E., Li, S., and Lee, R.J. Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med 4, 527, 2009.
25. Otsu, K., Das, S., Houser, S.D., Quadri, S.K., Bhattacharya, S., and Bhattacharya, J. Concentration-dependant inhibition of angiogenesis by mesenchymal stem cells. Blood 113, 18, 2009.
26. McCarthy, H.E., Bara, J.J., Brakspear, K., Singhrao, S.K., and Archer, C.W. The comparison of equine articular cartilage progenitor cells and bone marrow-derived stromal cells as potential cell sources for cartilage repair in the horse. Vet J 192, 345, 2012.
27. Wright, K.T., El Masri, W., Osman, A., Roberts, S., Chamberlain, G., Ashton, B.A., and Johnson, W.E. Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A. Biochem Biophys Res Commun 354, 559, 2007.
28. Mcilroy, M., O'Rourke, M., McKeown, S. R., Hirst, D.G., and Robson, T. Pericytes influence endothelial cell growth characterisics: Role of plasminogen activator inhibitor type 1 (PAI-1). Cardiovasc Res 69, 207, 2006.
29. Koerner, J., Nesic, D., Romero, J.D., Brehm, W., Mainil- Varlet, P., and Grogan, S.P. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells 24, 1613, 2006.
30. Williams, R., Khan, I.M., Richardson, K., Nelson, L., McCarthy, H.E., Analbelsi, T., Singhrao, S.K., Dowthwaite, G.P., Jones, R.E., Baird, D.M., Lewis, H., Roberts, S., Shaw, H. M., Dudhia, J., Fairclough, J., Briggs, T., and Archer, C.W. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS One 5, e13246, 2010.
31. Johnstone, B., Hering, T.M., Caplan, A.I., Goldberg, A.M., and Yoo, J.U. In vitro chondrogenesis of bone marrowderived mesenchymal progenitor cells. Exp Cell Res 238, 265, 1998.
32. Barry, F., Boynton, R.E., Liu, B., and Murphy, J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268, 189, 2001.
33. Murdoch, A.D., Grady, L.M., Ablett, M.P., Katopodi, T., Meadows, R.S., and Hardingham, T.E. Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: generation of scaffold-free cartilage. Stem Cells 25, 2786, 2007.
34. Kim, Y.-J., Kim, H.-J., and Im, G.-I. PTHrP promotes chondrogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs. Biochem Biophys Res Commun 373, 104, 2008.
35. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5, 6, 1999.
36. Hiraki, Y., Inoue, H., Iyama, K., Kamizono, A., Ochiai, M., Shukunami, C., Iijima, S., Suzuki, F., and Kondo, J. Identification of chondromodulin I as a novel endothelial cell growth inhibitor. J Biol Chem 272, 32419, 1997.
37. Hayami, T., Shukumani, C., Mitsui, K., Endo, N., Tokunaga, K., Kondo, J., Takahashi, H.E., and Hiraki, Y. Specific loss of chondromodulin-I gene expression in chondrosarcoma and the supression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett 458, 436, 1999.
38. Staton, C.A., Reed, M.W.R., and Brown, N.J. A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol 90, 195, 2009.
39. Potapova, I.A., Gaudette, G.R., Brink, P.R., Robinson, R.B., Rosen, M.R., Cohen, I.S., and Doronin, S.V. Mesenchymal stromal cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 25, 1761, 2007.
40. Bosnakovski, D., Mizuno, M., Kim, G., Ishiguro, T., Okumura, M., Iwanaga, T., Kadosawa, T., and Fujinaga, T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells in pellet cultural system. Exp Hematol 32, 502, 2004.
41. Danišovic, L., Lesný, P., Havlas, V., Teyssler, P., Syrová , Z., Kopá ni, M., Fujeriková , G., Trc, T., Syková , E., and Jendelová, P. Chondrogenic differentiation of human bone marrow and adipose tissue-derived mesenchymal stem cells. J Appl Biomed 5, 139, 2007.
42. Grellier, M., Bordenave, L., and Amédée, J. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 27, 562, 2009.
43. Harada, S., Nagy, J.A., Sullivan, K.A., Thomas, K.A., Endo, N., Rodan, G.A., and Rodan, S.B. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 93, 2490, 1994.
44. Deckers, M.M., Karperien, M., Van der Bent, C., Yamashita, T., Papapoulos, S.E., and Löwik, C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141, 1667, 2000.
45. Mayr-Wohlfart, U., Waltenberger, J., Hausser, H., Kessler, S., Günther, K.P., Dehio, C., Puhl, W., and Brenner, R.E. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30, 472, 2002.
46. Saleh, F.A., Whyte, M., and Genever, P.G. Effects of endothelial cells on human mesenchymal stem cell activity in a three-dimensional in vitro model. Eur Cell Mater 22, 242, 2011.
47. Hoch, A.I., Binder, B.Y., Genetos, D.C., and Leach, J.K. Differentiation- dependent secretion of proangiogenic factors by mesenchymal stem cells. PLos One 7, e35579, 2012.
48. Khouri, R.K., Koudsi, B., and Reddi, H. Tissue transformation into bone in vivo: a potential practical application. J Am Med Assoc 266, 14, 1991.
49. Kanczler, J.M., Ginty, P.J., White, L., Clarke, N.M.P., Howdle, S.M., Shakesheff, K.M., and Oreffo, R.O.C. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31, 6, 2010.
50. Li, Y., Chen, J., Chen, X.G., Wang, L., Gautam, S.C., Xu, Y.X., Katakowski, M., Zhang, L.J., Lu, M., Janakiraman, N., and Chopp, M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59, 514, 2002.
51. Neuhuber, B., Himes, B.T., Shumsky, J.S., Gallo, G., and Fischer, I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 1035, 73, 2005.
52. Crigler, L., Robey, R.C., Asawachaicharn, A., Gaupp, D., and Phinney, D.G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198, 54, 2006.
53. Carmeliet, P. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 4, 710, 2003.
54. Eichmann, A., Le Noble, F., Autiero, M., and Carmeliet, P. Guidance of vascular and neural network formation. Curr Opin Neurobiol 15, 108, 2005.